Feature | February 06, 2014 | Dave Fornell

New EP Mapping Systems Enter the U.S. Market

Systems offer Improved Speed and Accuracy

New electrophysiology (EP) ablation mapping/navigation systems recently entered the U.S. market, each offering technology the vendors say will speed procedure time and improve procedural accuracy.
 
Boston Scientific’s Rhythmia Mapping System, a 3-D mapping and navigation system, gained U.S. Food and Drug Administration (FDA) 510(k) clearance in 2013. It is designed to intelligently automate map creation, increase speed and improve the density of mapping, capturing thousands versus hundreds of data points. The system also features vMap, a validation map, which is designed to enable EPs to rapidly confirm the endpoints of the ablation treatment. The intelligence built into the system also helps eliminate the need for manual annotation.
 
The Rhythmia mapping system works with Boston Scientific’s 64-electrode IntellaMap Orion high-resolution mapping catheter.
 
FIRM Rotor Mapping
Atrial fibrillation has proved to be an incredibly challenging arrhythmia to treat, and its complexity has defied interpretation and visualization by traditional EP mapping approaches. A relatively new technique has been developed using basket-mapping catheters to directly image myocardial bio-electrical rotors, an EP phenomenon shown in clinical studies to sustain atrial fibrillation.
 
Topera Inc. received 510(k) clearance in December for the latest generation of its 3D Mapping System. The new system has faster processing times, providing near-instantaneous intra-procedural mapping and re-mapping capabilities. The system incorporates a new color-imaging module to aid identification of rotors, an EP phenomenon previously shown to sustain atrial fibrillation. These functionalities enable EPs to more efficiently diagnose and ablate the cause of these complex arrhythmias.
 
Topera also gained approval for its FIRMap panoramic contactmapping basket catheter in the United States and Europe in late 2013. FIRMap is the first and only contact-mapping basket catheter cleared by the FDA for use in all cardiac chambers to assist in the diagnosis of complex arrhythmias. 

Related Content

News | EP Mapping and Imaging Systems
April 29, 2022 – Vektor Medical has announced positive results from its “Vektor vMap Clinical Validation Study” ...
Home April 29, 2022
Home
News | EP Mapping and Imaging Systems

March 3, 2022 – CIRCA Scientific, Inc. has announced that its S-CATH M Esophageal Temperature Probe is now cleared for ...

Home March 03, 2022
Home
Videos | EP Mapping and Imaging Systems

An example of the Acutus Medical AcQMap High Resolution Imaging and Mapping System to guide electrophysiology (EP) ...

Home October 14, 2021
Home
News | EP Mapping and Imaging Systems

September 29, 2020 — The U.S. Food and Drug Administration (FDA) granted 510(k) clearance for the second-generation of ...

Home September 29, 2020
Home
News | EP Mapping and Imaging Systems

September 14, 2020 — Philips Healthcare released new imaging and workflow enhancements for its novel Kodex-EPD cardiac ...

Home September 14, 2020
Home
News | EP Mapping and Imaging Systems

August 17, 2020 — A Northwestern Medicine Bluhm Cardiovascular Institute physician was the first electrophyiologist in ...

Home August 17, 2020
Home
News | EP Mapping and Imaging Systems

October 15, 2019 — Kardium Inc. announced that the Globe mapping and ablation system has successfully demonstrated ...

Home October 15, 2019
Home
News | EP Mapping and Imaging Systems

October 9, 2019 — Acutus Medical and Innovative Health announced a partnership that will offer advanced ...

Home October 09, 2019
Home
News | EP Mapping and Imaging Systems

August 19, 2019 — Scientists at Johns Hopkins have successfully created personalized digital replicas of the upper ...

Home August 19, 2019
Home
News | EP Mapping and Imaging Systems

July 15, 2019 — Acutus Medical announced the publication of the UNCOVER AF study in Circulation: Arrhythmia and ...

Home July 15, 2019
Home
Subscribe Now